{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:31:41Z","timestamp":1788273101104,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jgar.2021.12.008","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T02:49:54Z","timestamp":1639968594000},"page":"67-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults"],"prefix":"10.1016","volume":"28","author":[{"given":"Marc D.","family":"Esquivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-458X","authenticated-orcid":false,"given":"Marguerite L.","family":"Monogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5833-3532","authenticated-orcid":false,"given":"James D.","family":"Finklea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2021.12.008_bib0001","unstructured":"Cystic Fibrosis Foundation. 2020 Patient Registry Annual Data Report. https:\/\/www.cff.org\/medical-professionals\/patient-registry [accessed 10 January 2022]."},{"issue":"1 Suppl","key":"10.1016\/j.jgar.2021.12.008_bib0002","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","article-title":"Structure and function of the CFTR chloride channel","volume":"79","author":"Sheppard","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jgar.2021.12.008_bib0003","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2021.12.008_bib0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ppul.20604","article-title":"Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function","volume":"42","author":"Ren","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jgar.2021.12.008_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1060028019885651","article-title":"Comparative effectiveness of vancomycin versus linezolid for the treatment of acute pulmonary exacerbations of cystic fibrosis","volume":"54","author":"Fusco","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgar.2021.12.008_bib0006","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.02371-13","article-title":"Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy","volume":"58","author":"Casapao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.008_bib0007","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jcf.2017.10.010","article-title":"Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis","volume":"17","author":"Barsky","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2021.12.008_bib0008","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/jcm8060824","article-title":"Efficacy and safety of ceftaroline for the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials","volume":"8","author":"Lan","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgar.2021.12.008_bib0009","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/ppul.25029","article-title":"Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis","volume":"55","author":"Branstetter","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jgar.2021.12.008_bib0010","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.008_bib0011","doi-asserted-by":"crossref","first-page":"ofz168","DOI":"10.1093\/ofid\/ofz168","article-title":"Ceftaroline-associated neutropenia: case series and literature review of incidence, risk factors, and outcomes","volume":"6","author":"Sullivan","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.008_bib0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/AAC.01471-15","article-title":"Neutropenia associated with long-term ceftaroline use","volume":"60","author":"Lavie","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.008_bib0013","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:59:55Z","timestamp":1761991195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":13,"alternative-id":["S2213716521002800"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.12.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}